Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Circadian Rhythm Sleep-Wake Disorders in Night Workers
NCT07382843Phase 4Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramelteon in circadian rhythm sleep-wake disorder (CRSWD), sponsored by Tri-Service General Hospital. Started Mar 2024; status: completed.
02
Drugs
ramelteon
03
Conditions
circadian rhythm sleep-wake disorder (CRSWD)
Beyond the preview
Go deeper on NCT07382843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07382843.